Interest in the microbiome has grown rapidly over the past decade. What is becoming increasingly clear, however, is that simply modulating the microbiota is not enough. The more relevant question is how specific ingredients influence microbial metabolism and whether those changes generate biologically meaningful signals.
A recent study published in Food Bioscience explored this interaction using Csat®, a standardized carob-based formulation, in a controlled in vitro model based on human fecal microbiota. The objective was not to assess appetite or weight changes, but to better understand how Csat® influences microbial activity and short-chain fatty acid (SCFA) production
A Closer Look at SCFAs
Acetate, propionate and butyrate are central metabolites produced when gut bacteria utilize non-digestible nutrients. These compounds have been associated in the scientific literature with several physiological pathways, including signaling through FFAR2 and FFAR3 receptors and the modulation of hormones such as GLP-1 and PYY. The relationship between SCFAs and host metabolism is complex and context-dependent. For this reason, mechanistic models are valuable tools for clarifying upstream microbial and metabolic effects before moving into clinical research.
What Was Evaluated
In this study, researchers incubated human gut microbiota under anaerobic conditions and compared Csat® with a control medium and two individual carob fractions (a galactomannan-rich seed fraction and a pulp extract).
They assessed:
- Changes in microbial composition (full-length 16S rRNA sequencing)
- SCFA concentrations over time (measured by GC-FID)
- Predicted functional capacity using bioinformatic tools (PICRUSt2, COG and CAZy databases)
What Changed with Csat®
After 24 hours, Csat® showed higher SCFA production (Figure 1) compared to control:
-
Acetate: 71.5 mM vs 51.8 mM
-
Propionate: 52.8 mM vs 33.7 mM
-
Butyrate: 48.6 mM vs 34.3 mM
Importantly, while the galactomannan-rich fraction (GM) and the pulp extract (CPE) each induced fermentation responses, Csat® consistently generated the highest and most sustained levels of all three major SCFAs, particularly at 48 hours.
GM showed strong early activation of carbohydrate-degrading potential, whereas CPE induced a broader but more transient microbial response. In contrast, Csat® integrated these complementary effects, maintaining targeted enrichment of Bacteroides species while supporting butyrate-associated genera such as Anaerostipes and Blautia. Concurrently, reduced isovalerate levels under Csat® suggested a metabolic shift away from proteolytic fermentation and toward sustained carbohydrate-driven metabolism.
Figure 1. Short-chain fatty acid (SCFA) concentrations (mM) in control and treatment groups (Csat®, GM, and CPE) after 24 h and 48 h of fermentation. Data are shown as mean ± SD (n = 3). Statistical differences were assessed by one-way ANOVA followed by Tukey’s post hoc test (p < 0.05). Different letters above bars indicate significant differences among groups within each time point.
Correlation analyses (Figure 2) further indicated coordinated activity between primary degraders and secondary fermenters under Csat®, consistent with cross-feeding dynamics known to sustain SCFA generation.
Figure 2. Pearson’s correlation between relative abundance of the 10 most abundant bacterial genera and short-chain fatty acids (SCFAs) during fecal fermentation of Csat®. (A) Correlations at 24 h and (B) at 48 h of fermentation. Circle size represents the absolute value of the correlation coefficient, and color scale indicates the direction and strength of the association (brown = positive, beige = negative). Only significant associations (p < 0.05) are shown.
Functional predictions revealed a temporally coherent pattern. The GM fraction showed early enrichment of glycosidase-related signatures consistent with rapid extracellular depolymerization of complex carbohydrates. In contrast, Csat® exhibited a later increase in predicted sugar transport systems, particularly ATP-binding cassette (ABC) transporters, suggesting enhanced uptake and intracellular processing of fermentation products over time.
This integrated functional profile, combining hydrolytic activation and sustained substrate transport, was not observed to the same extent with the isolated fractions. It provides a mechanistic explanation for the higher and more sustained SCFA production under Csat® fermentation.
While these functional inferences are based on predictive bioinformatic tools rather than direct enzyme activity measurements, they are consistent with the metabolite output and taxonomic shifts observed.
Taken together, these findings support the biological plausibility of a microbiota-mediated pathway in which coordinated carbohydrate depolymerization, cross-feeding dynamics, and efficient substrate utilization converge to enhance SCFA production, a process mechanistically linked in the broader literature to satiety-related signaling pathways.
Why This Matters
The microbiome field is moving beyond generalized claims of microbiota modulation toward a mechanistic understanding of how specific, standardized ingredients reshape microbial metabolism.
In this context, Csat® stands apart. Unlike isolated carob fractions, Csat® is a fully characterized and standardized formulation integrating multiple bioactive components under controlled manufacturing conditions. This compositional precision enables reproducible functional outcomes, as illustrated in the integrated fermentation model shown in Figure 3.
By combining complementary structural fractions of carob, Csat® promotes coordinated carbohydrate depolymerization, substrate uptake, and sustained short-chain fatty acid production. This integrated microbial response links directly to biological pathways involved in:
- Satiety signaling through the gut–brain axis.
- Enteroendocrine hormone modulation (GLP-1, PYY).
- Energy metabolism and substrate partitioning.
- Systemic metabolic regulation
Quantifying metabolite output, identifying taxonomic shifts, and predicting functional capacity provides a mechanistic bridge between ingredient composition and physiological relevance.
In this way, the study does not simply demonstrate microbiota changes, it supports a rational, evidence-based framework for developing metabolically active ingredients designed to interact with the gut–brain–metabolic axis.
About the Research
The study was led by Iván Benito Vázquez in collaboration with researchers from the Instituto de Investigación en Ciencias de la Alimentación (CIAL-CSIC) and Pharmactive Biotech Products. This collaboration illustrates the integration of academic research and industrial standardization in the development of evidence-based botanical ingredients.
References
Benito-Vázquez, I., Yépez-Notario, C., Díez-Municio, M., Requena, T., & Moreno, F. J. (2026). Unveiling the microbiome-mediated potential of a carob-based formulation (Csat®): human fecal fermentation, SCFA production, and potential connections with satiety pathways. Food Bioscience, 78, 108472. https://doi.org/10.1016/j.fbio.2026.108472
